VIEL & Cie : First-half 2015 Results Operating profit up 57% to €36.1m Net profit - Group share up 32% to €16.8m
September 04, 2015 01:30 ET
|
VIEL ET COMPAGNIE
First-half 2015 Results Operating profit up 57% to €36.1m Net profit - Group share up 32% to €16.8m €m First half 2015 First half 2014 Var 2014/2015 Consolidated revenue 423.2 ...
VIEL & Cie : Résultat du 1er semestre 2015: Résultat d'exploitation en hausse de 57 % à 36,1 M€, Augmentation du résultat net - part de groupe de 32 % à 16,8 M€
September 04, 2015 01:30 ET
|
VIEL ET COMPAGNIE
Résultat du 1er semestre 2015 Résultat d'exploitation en hausse de 57 % à 36,1 M€ Augmentation du résultat net - part de groupe de 32 % à 16,8 M€ En millions d'euros 1er semestre 2015 1er...
BW Offshore: Mandatory notification of trade
September 04, 2015 01:30 ET
|
BW Offshore
Christophe Pettenati-Auzière, member of the Board of Directors in BW Offshore, yesterday purchased 50,000 shares in BW Offshore Limited of NOK 3.65 per share. Following this transaction, Mr....
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP) - Net Asset Value(s)
September 04, 2015 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR) - Net Asset Value(s)
September 04, 2015 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Nicox propose un regroupement d'actions et convoque ses actionnaires en Assemblée Générale Extraordinaire
September 04, 2015 01:30 ET
|
NICOX SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Nicox propose un regroupement...
Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma
September 04, 2015 01:15 ET
|
Novartis Pharma AG
Farydak (panobinostat) combination is approved in the EU for patients with multiple myeloma who received >=2 prior regimens including bortezomib and IMiD[1] In clinical trials, Farydak...
Fagron NV: Disclosure of received notification
September 04, 2015 01:00 ET
|
Fagron NV
Regulated information Waregem (Belgium)/Rotterdam (Netherlands)[1], 4 September 2015 Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies,...
AMG Advanced Metallurgical Group N.V. Announces Interim Dividend
September 04, 2015 01:00 ET
|
AMG Critical Materials N.V.
Amsterdam, 4 September 2015 --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to announce an interim dividend in respect of the period from 1 January 2015 to...
Celyad Announces the Appointment of Dr. Debasish Roychowdhury as Independent Director
September 04, 2015 01:00 ET
|
Celyad
MONT-SAINT-GUIBERT, Belgium, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, today...
- April 23, 2024 17:27 ET Twill Payments Secures Pre-Seed Funding to Revolutionize Data Analytics with AI
- April 23, 2024 17:17 ET MINSAMA LLC Unveils L3849 Diamond Plate - A Quantum Leap in Thermal Management for Electronics